BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRML
3376
DELISTED
Tourmaline Bio
TRML
| $11.4M | ﹤0.01% |
252,061
+8,670
| +4% | +$684K |
|
|
VLDR
3377
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $11.4M | ﹤0.01% |
11,894,413
+6,021,712
| +103% | +$10.4M |
|
|
OZON
3378
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $11.3M | ﹤0.01% |
1,200,004
| – | – |
|
3379
Teekay
TK
$955M
| $11.3M | ﹤0.01% |
3,917,818
-72,091
| -2% | -$236K |
|
3380
Inspired Entertainment
INSE
$181M
| $11.3M | ﹤0.01% |
1,308,972
+944,824
| +259% | +$9.63M |
|
3381
Altimmune
ALT
$595M
| $11.3M | ﹤0.01% |
962,184
-1,974,140
| -67% | -$12.2M |
|
3382
Stratasys
SSYS
$782M
| $11.2M | ﹤0.01% |
600,143
+228,100
| +61% | +$4.49M |
|
|
LFAC
3383
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
| $11.2M | ﹤0.01% |
+1,125,000
| New | +$11.2M |
|
|
MN
3384
DELISTED
MANNING & NAPIER, INC.
MN
| $11.2M | ﹤0.01% |
897,951
+750,494
| +509% | +$9.43M |
|
3385
Tecnoglass Holdings Inc.
TGLS
$2.1B
| $11.2M | ﹤0.01% |
637,067
-357,922
| -36% | -$7.6M |
|
|
TEAD
3386
Teads Holding Co
TEAD
$76.4M
| $11.1M | ﹤0.01% |
2,215,422
+898,056
| +68% | +$6.76M |
|
3387
Genius Sports
GENI
$2.2B
| $11.1M | ﹤0.01% |
4,942,952
+31,979
| +0.7% | +$108K |
|
|
WHWK
3388
Whitehawk Therapeutics
WHWK
$210M
| $11.1M | ﹤0.01% |
902,677
+592,550
| +191% | +$8.8M |
|
|
VBIV
3389
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $11.1M | ﹤0.01% |
456,923
+16,219
| +4% | +$552K |
|
3390
iShares Russell 2000 Growth ETF
IWO
$15B
| $11.1M | ﹤0.01% |
53,696
-20,046
| -27% | -$4.47M |
|
3391
Riverview Bancorp
RVSB
$109M
| $11.1M | ﹤0.01% |
1,681,933
-14,571
| -0.9% | -$100K |
|
|
USER
3392
DELISTED
UserTesting, Inc.
USER
| $11M | ﹤0.01% |
2,199,188
+979,945
| +80% | +$6.58M |
|
|
JBIO
3393
Jade Biosciences
JBIO
$1.3B
| $11M | ﹤0.01% |
20,153
-1,188
| -6% | -$567K |
|
3394
monday.com
MNDY
$3.83B
| $11M | ﹤0.01% |
106,815
+73,515
| +221% | +$8.93M |
|
3395
West Fraser Timber
WFG
$5.52B
| $11M | ﹤0.01% |
143,190
+53,604
| +60% | +$4.52M |
|
3396
Century Therapeutics
IPSC
$363M
| $11M | ﹤0.01% |
1,306,185
+277,928
| +27% | +$2.73M |
|
3397
FVCBankcorp
FVCB
$341M
| $11M | ﹤0.01% |
727,708
+614,410
| +542% | +$9.83M |
|
|
SNP
3398
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $10.9M | ﹤0.01% |
244,094
+134,667
| +123% | +$6.64M |
|
|
DADA
3399
DELISTED
Dada Nexus
DADA
| $10.9M | ﹤0.01% |
1,346,901
-970,686
| -42% | -$7.46M |
|
|
ACLX
3400
DELISTED
Arcellx
ACLX
| $10.9M | ﹤0.01% |
602,511
+102,406
| +20% | +$1.32M |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.